Biochemistry News and Research

RSS

Discovery of binocular vision gene

A team of researchers at the Bosch Institute have identified an important gene responsible for binocular vision.

19 Oct 2007

Defects in Jhdm2a gene could be the cause for some cases of male infertility

Scientists at the University of North Carolina at Chapel Hill have identified a gene crucial to the final step of the formation of a functional sperm cell.

18 Oct 2007

Proteins that underlie cancer

A University of Arkansas scientist who studies constructs of a protein that are associated with the cell transformation that causes cancer has received a five-year, $661,018 grant from the National Institutes of Health to expand his research.

17 Oct 2007

Structure of influenza B virus protein gives clues to next pandemic

Determining the structure of a protein called hemagglutinin on the surface of influenza B is giving researchers at Baylor College of Medicine and Rice University in Houston clues as to what kinds of mutations could spark the next flu pandemic.

17 Oct 2007

Scientists map flu's chemical key

Scientists from Baylor College of Medicine (BCM) and Rice University have developed a three-dimensional, molecular map that could yield clues about the genetic mutations that will allow bird flu to spread among humans.

17 Oct 2007

Homocysteine appears to be play a part in retinal damage and vision loss

Homocysteine, an amino acid believed to contribute to heart attack, stroke and dementia, likely also is a player in retinal damage and vision loss, researchers say.

16 Oct 2007

Important insights into blood vessel formation

Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels.

15 Oct 2007

Transthyretin protein may accelerate atherosclerosis

Scientists report in the November 2007 issue of the Journal of Lipid Research that a protein called transthyretin (TTR) that is present in the blood may accelerate the development of atherosclerosis - a potentially fatal heart disease in which the arteries are progressively narrowed and hardened over time, reducing blood flow to the heart.

12 Oct 2007

Peripheral ehanolamine plasmalogen deficiency - likely factor in Alzheimer's and dementia

Dayan B. Goodenowe and colleagues report in the November 2007 issue of the Journal of Lipid Research that people with Alzheimer's disease and related conditions exhibit decreased blood levels of an important brain chemical called ethanolamine plasmalogen, even at the very early stages of the disease.

12 Oct 2007

Potential health benefits of fish oil in baby formula

Scientists report in the November 2007 issue of the Journal of Lipid Research that adding long-chain polyunsaturated fatty acids - typically found in fish oil - to baby formula may help infants better regulate their blood sugar and make more proteins in their muscle cells.

12 Oct 2007

Compound called apolipoprotein B in blood better at predicting coronary heart disease in Chinese people

Scientists report in the November 2007 issue of the Journal of Lipid Research that the concentration of a compound called apolipoprotein B in the blood is better at predicting whether Chinese have coronary heart disease – in which fatty deposits clog arteries that supply blood and oxygen to the heart – than other substances such as blood cholesterol levels.

12 Oct 2007

Anticlotting drug found to be safe in sickle cell patients

An intravenous "blood thinner" widely used in patients with acute coronary syndromes and during coronary artery stent placement appears to be safe in patients with sickle cell disease and may have beneficial anti-inflammatory effects, a small study at the University of North Carolina at Chapel Hill School of Medicine has found.

12 Oct 2007

Mario Capecchi shares Nobel Prize in medicine for knockout mice technology

Mario R. Capecchi, Ph.D., distinguished professor of human genetics and biology at the University of Utah's Eccles Institute of Human Genetics and a Howard Hughes Medical Institute investigator, has won the 2007 Nobel Prize in Physiology or Medicine.

9 Oct 2007

Sir Martin Evans wins Nobel prize for stem cell research

Medical Research Council funded scientist Sir Martin Evans, has been awarded the Nobel Prize in Physiology or Medicine for 2007 alongside Mario R. Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells".

9 Oct 2007

Completion of first clinical trial of Apatone for cancer treatment

In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.

8 Oct 2007

Researchers report most complete list so far of the proteins present in the cerebral cortex

Researchers report in the October 2007 issue of Molecular & Cellular Proteomics the most complete list so far of the proteins present in the cerebral cortex – the outermost layer of the brain that plays a central role in memory, language, cognition, and consciousness.

8 Oct 2007

Proteins found that could be used to improve diagnosis of hepatocellular carcinoma

Researchers report in the October 2007 issue of Molecular & Cellular Proteomics that they have identified proteins that could be used to improve the diagnosis of hepatocellular carcinoma, the most common type of liver cancer.

8 Oct 2007

Improving diagnosis of cancer by detecting protein-sugar structures

Researchers report in the October 2007 issue of Molecular & Cellular Proteomics that they have developed a new way of detecting the abnormal presence of complexes of sugars and proteins in the blood of cancer patients, thus providing a new tool for cancer diagnosis.

8 Oct 2007

Discovery offers hope of halting motor neurone disease progression

Scientists have discovered a causal link between the gene for a small protein involved in the formation of blood vessels and the development of some forms of motor neurone disease.

4 Oct 2007

Missouri-Columbia researchers look at mechanisms of cisplatin drug sensitivity

Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.

3 Oct 2007